Sam Loveless
Cardiff, WLS, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Non-invasive biomarkers for Neurosarcoidosis: Complement activation as a tool for diagnosis and prognosis.
Journal: Journal of neuroimmunology
Published: January 03, 2026
Bloodstream infections and Blood-Brain barrier Permeability: An observational cohort study.
Journal: Brain, behavior, and immunity
Published: November 07, 2025
Genetic subtypes associated with multiple sclerosis severity and response to treatment.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: August 05, 2025
Subcutaneous administration of natalizumab can lead to lower drug concentrations compared to intravenous administration.
Journal: Multiple sclerosis and related disorders
Published: April 11, 2024
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes.
Journal: Journal of neuroinflammation
Published: October 09, 2023
Relevance of Multiple Sclerosis Severity Genotype in Predicting Disease Course: A Real-World Cohort.
Relevance of Multiple Sclerosis Severity Genotype in Predicting Disease Course: A Real-World Cohort.
Journal: Annals of neurology
Published: July 20, 2023
CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis.
Journal: Journal of neuroinflammation
Published: August 20, 2020
Serum neurofilament-light concentration and real-world outcome in MS.
Journal: Journal of the neurological sciences
Published: May 04, 2020
Using biomarkers to predict clinical outcomes in multiple sclerosis.
Journal: Practical neurology
Published: March 25, 2019
Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 10, 2018
Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis.
Journal: Brain pathology (Zurich, Switzerland)
Published: December 20, 2016
Complement is activated in progressive multiple sclerosis cortical grey matter lesions.
Journal: Journal of neuroinflammation
Published: March 18, 2016
Last Updated: 09/26/2026